BioSpace News Archive

Policy

Bristol-Myers Squibb Company, Pfizer Inc. to Seek Apixaban Approval

December 7, 2009
·
1 min read
Policy

Nutra Pharma Corp. Completes FDA Submission for Nyloxin OTC and Nyloxin Rx – Over-the-Counter and Prescription Treatments for Chronic Pain

December 7, 2009
·
1 min read
Policy

Somaxon Pharmaceuticals, Inc. Receives Complete Response Letter from the FDA for Silenor(R), NDA Not Approved

December 7, 2009
·
6 min read
FDA

FDA Grants First Approval for Dyax Corp.'s (JOBS) Product Derived from Pichia Pastoris

December 7, 2009
·
2 min read
Business

Celgene (JOBS) to Buy Gloucester Pharmaceuticals, Inc. in Cancer Drug Deal; Celgene to Pay $340 Million in Cash, $300 Million in Milestones

December 7, 2009
·
5 min read
Business

Infinity Pharmaceuticals, Inc. Names Adelene Q. Perkins Chief Executive Officer

December 7, 2009
·
6 min read
Eisai Company, Ltd. Launches New Oral Jelly Formulation of Aricept(R), World’s First Oral Jelly for Alzheimer’s Disease Treatment

December 7, 2009
·
1 min read
Drug Development

Millennium: The Takeda Oncology Company’s VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma

December 7, 2009
·
1 min read
Biotech Beach

PerkinElmer, Inc. Launches New AlphaScreen(R) SureFire(R) and AlphaLISA(R) “No Wash” Immunoassay and Cellular Pathway Mapping Kits

December 7, 2009
·
2 min read
FDA

ATS Medical, Inc. Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis

December 7, 2009
·
5 min read